BRAINSTORM CELL THERAPEUTICS INC. - BCLI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | — | A | A | 100,000.0 | 0.0 | 0.0 | 343,777.0 | View | |
| Jul 28, 2026 | Executive Chairman | A | A | 900,000.0 | 0.0 | 0.0 | 900,000.0 | View | |
| May 29, 2026 | President & CEO | A | A | 1,800,000.0 | 0.0 | 0.0 | 2,000,960.0 | View | |
| May 29, 2026 | EVP & Chief Business Officer | A | A | 150,000.0 | 0.0 | 0.0 | 218,464.0 | View | |
| May 29, 2026 | See Remarks | A | A | 100,000.0 | 0.0 | 0.0 | 144,349.0 | View | |
| May 29, 2026 | — | A | A | 200,000.0 | 0.0 | 0.0 | 243,777.0 | View | |
| May 29, 2026 | — | A | A | 120,000.0 | 0.0 | 0.0 | 161,054.0 | View | |
| May 20, 2026 | — | A | A | 150,000.0 | 0.7 | 105,000.0 | 150,000.0 | View | |
| May 20, 2026 | — | A | A | 150,000.0 | 0.7 | 105,000.0 | 150,000.0 | View | |
| May 20, 2026 | — | A | A | 225,000.0 | 0.7 | 157,500.0 | 225,000.0 | View | |
| May 20, 2026 | — | A | A | 150,000.0 | 0.7 | 105,000.0 | 150,000.0 | View | |
| May 20, 2026 | — | A | A | 180,000.0 | 0.7 | 126,000.0 | 180,000.0 | View | |
| May 20, 2026 | — | A | A | 225,000.0 | 0.7 | 157,500.0 | 225,000.0 | View |